Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Lancet. 2010 Mar 5;375(9725):1557–1568. doi: 10.1016/S0140-6736(09)61999-1

Table 2.

Situations in which to consider use of antimicrobial therapy following incision and debridement of a CA-MRSA SSTI.

Severe or extensive disease and/or rapid progression in presence of associated cellulitis
Signs and symptoms of systemic illness
Associated comorbidities or immune suppression (DM, HIV/AIDS, neoplastic disease)
Extremes of age
Abscess in area difficult to drain
Associated septic phlebitis
Lack of response of treatment with incision and drainage alone